AI Terminal
Elanix Biotechnologies AG
Board/Management Information • Apr 18, 2019
136_rns_2019-04-18_1a1d97d4-bf04-466f-ae65-5415f758abd2.html
Board/Management Information
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 18 April 2019 09:30
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Elanix Biotechnologies AG / Key word(s): Personnel
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
18-Apr-2019 / 09:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
ELANIX BIOTECHNOLOGIES AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Berlin, April 18 2019 – The Supervisory Board of Elanix Biotechnologies AG (“Company”, “Elanix”) has nominated by juridical order Professor Zhanfeng Cui and Anja Silling to become members of the Supervisory Board with immediate effect.
Today, the Supervisory Board of Elanix has nominated Anja Silling to become the Chairman of the Board and Fang Bao, an existing member of the board, to be the Vice Chairman.
Lee Ann Laurent-Applegate
CEO
18-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Elanix Biotechnologies AG |
| Stadthausbrücke 1-3 | |
| 20355 Hamburg | |
| Germany | |
| Phone: | +41 22 363 66 40 |
| Fax: | +41 22 363 66 41 |
| E-mail: | [email protected] |
| Internet: | www.elanixbiotechnologies.com |
| ISIN: | DE000A0WMJQ4 |
| WKN: | A0WMJQ |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 801589 |
| End of Announcement | DGAP News Service |